Genetic Technologies Ltd (GENE) Stock News
NASDAQ:GENE - Nasdaq - US37185R4065 - ADR - Currency: USD
GENE Latest News, Press Relases and Analysis
Bullish Monday For Marijuana Stocks - Body and Mind, Global Compliance Among Top Gainers
Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on October 2
MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic...
Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics
MELBOURNE, Australia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...
Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform
CHARLOTTE, N.C., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...
Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on August 15
MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”),...
Genetic Technologies Strategic Restructure Driving USA Sales Growth
CHARLOTTE, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...
Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
MELBOURNE, Australia, July 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in...
Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
GeneType to Enter Canadian and New Zealand Markets
GeneType to Enter Canadian and New Zealand Markets...
GeneType to Enter Canadian and New Zealand Markets
Genomics-based testing brand expands international presence as pilot influencer campaign fuels sales
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease...
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
Results from commercial sales of predictive testing across the US and Australia establish clear advantages of geneType Risk Assessment Tests for a more preventive approach in disease management
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27...